Company intelligence / Profile preview

Kaiima Bio-Agritech

Moshav Sharona, Lower Galilee, Israelfinder.startupnationcentral.org ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Kaiima Bio-Agritech has developed and commercialized high-yield castor hybrids using its proprietary CastorMaxx® platform. Its EP™ non-GMO genome diversity induction technology has been applied to multiple crops. The company partners with seed companies and research institutes globally to improve crop yields for food, feedstocks, biofuels, and biomaterials. No clinical results as it is not a therapeutics developer.

Modalities: Non-GMO plant breeding technologyHybrid crop development
Industry: Agriculture & AgTech

Partnerships

Bayer CropScience (hybrid rice partnership)Kunshan Keteng Biological Science & Technology Co. (EP corn varieties commercialization)International Rice Research Institute IRRI

Beyond the preview

Go deeper on Kaiima Bio-Agritech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaiima Bio-Agritech.

Explore the full profile